Work

Phase I study of tipifarnib and sorafenib in patients with biopsiable advanced cancers (NCI protocol 7156 supported by NCI grant UO1 CA062461)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3549

Authors: D. S. Hong, L. Camacho, C. Ng, J. Wright, R. A. Newman, S. Moulder, N. Tannir, J. Wheler, R. Khan, R. Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, National Cancer Institute

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W42008395

Cites:

Cited by: 10

Related to: 10